Archetype Wealth Partners Bristol Myers Squibb CO Transaction History
Archetype Wealth Partners
- $600 Million
- Q1 2024
A detailed history of Archetype Wealth Partners transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Archetype Wealth Partners holds 6,791 shares of BMY stock, worth $303,286. This represents 0.06% of its overall portfolio holdings.
Number of Shares
6,791Holding current value
$303,286% of portfolio
0.06%Shares
7 transactions
Others Institutions Holding BMY
# of Institutions
2,490Shares Held
1.49BCall Options Held
26MPut Options Held
20M-
Vanguard Group Inc Valley Forge, PA186MShares$8.31 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY163MShares$7.26 Billion0.21% of portfolio
-
State Street Corp Boston, MA91.6MShares$4.09 Billion0.23% of portfolio
-
Jpmorgan Chase & CO New York, NY88.8MShares$3.97 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$3.14 Billion0.79% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $95B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...